Table 1 Baseline clinical characteristics of participants
From: Quality of life and pain in premenopausal women with major depressive disorder: The POWER Study
Controls n = 36 | MDD n = 70 | P | |
|---|---|---|---|
Age (years) | 35.4 +/- 6.4 | 35.4 +/- 6.6 | n.s. |
Race | |||
Caucasian | 91.7% | 91.4% | n.s. |
Other | 8.3% | 8.6% | n.s. |
BMI (kg/m2) | 24.4 +/- 3.7 | 26.6 +/- 6.4 (n = 69) | n.s. |
Urinary-free cortisol (nmol/L) | 170.9 +/- 83.4 (n = 30) | 141.4 +/- 55.4 (n = 28) | n.s. |
Hamilton Scale for Anxiety | 1.2 +/- 1.7 (n = 35) | 7.0 +/- 5.3 (n = 68) | <0.0001 |
Hamilton Scale for Depression | 1.4 +/- 1.9 (n = 34) | 9.4 +/- 7.7 (n = 69) | <0.0001 |
Depressive Episode Questionnaire | n/a | (n = 53) | |
Age at Onset of Depression | n/a | 18.3 +/- 8.6 | n.s. |
# of Depressive Episodes | n/a | 4.4 +/- 2.7 | n.s. |
Cumulative Duration of Depression (months) | n/a | 71.6 +/- 84.2 | n.s. |